Amedisys (NASDAQ:AMED) Sees Large Volume Increase

Amedisys, Inc. (NASDAQ:AMED) saw unusually-strong trading volume on Tuesday . Approximately 248,407 shares traded hands during trading, a decline of 16% from the previous session’s volume of 294,641 shares.The stock last traded at $96.21 and had previously closed at $96.68.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on AMED. William Blair downgraded shares of Amedisys from an “outperform” rating to a “market perform” rating in a research report on Monday. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a research note on Thursday, April 25th. StockNews.com upgraded Amedisys from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Finally, Royal Bank of Canada lifted their target price on Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, March 25th. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Amedisys has an average rating of “Hold” and an average price target of $100.67.

Amedisys Trading Down 0.3 %

The business’s 50 day moving average price is $93.20 and its two-hundred day moving average price is $93.44. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.09. The company has a market capitalization of $3.15 billion, a price-to-earnings ratio of -150.33, a price-to-earnings-growth ratio of 2.25 and a beta of 0.79.

Amedisys (NASDAQ:AMED) last announced its earnings results on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, topping the consensus estimate of $1.02 by $0.01. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The firm had revenue of $571.41 million for the quarter, compared to analysts’ expectations of $565.38 million. During the same quarter in the previous year, the company earned $1.00 earnings per share. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. Equities analysts forecast that Amedisys, Inc. will post 4.57 earnings per share for the current fiscal year.

Institutional Trading of Amedisys

Several institutional investors and hedge funds have recently added to or reduced their stakes in AMED. Water Island Capital LLC increased its stake in Amedisys by 185.0% in the 4th quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock worth $67,559,000 after purchasing an additional 461,368 shares in the last quarter. Norges Bank purchased a new position in shares of Amedisys in the fourth quarter worth approximately $34,032,000. Segantii Capital Management Ltd acquired a new stake in shares of Amedisys during the fourth quarter valued at approximately $32,776,000. Calamos Advisors LLC purchased a new stake in shares of Amedisys in the 4th quarter valued at approximately $23,015,000. Finally, Alpine Associates Management Inc. boosted its stake in Amedisys by 23.0% in the 4th quarter. Alpine Associates Management Inc. now owns 1,271,097 shares of the health services provider’s stock worth $120,830,000 after purchasing an additional 237,600 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.